Orchestra BioMed Reports Q3 2026 Results and Recent Business Updates
FROM THE WIRE · MANILATIMES.NET
BACKBEAT Global Pivotal Trial evaluating AVIM Therapy completed enrollment and exceeded enrollment target, with a total of 349 patients randomized.BACKBEAT Trial primary endpoint data planned to be submitted for late-breaking presentation at the Heart Rhythm Society 2027 ('HRS…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralQuarterly update from a biomedical company with clinical and regulatory progress relevant to its sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01The BACKBEAT pivotal trial completed enrollment with 349 patients randomized.
- 02Medtronic plans to submit a PMA supplement for AVIM Therapy after data presentation.
- 03The company raised approximately $80.5 million in net proceeds through a public offering.